Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy
C Colosimo1, P Lebon, M Martelli
1International Medical Service, Roma, Italy.
Acta Neurologica Belgica
|January 1, 1992
Summary
This study reports a probable case of progressive multifocal leukoencephalopathy (PML) in a patient with non-Hodgkin's lymphoma. Treatment with alpha-interferon led to significant neurological and MRI improvement.
Area of Science:
- Neurology
- Oncology
- Immunology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare, often fatal, demyelinating disease of the central nervous system.
- PML is caused by the JC virus, typically occurring in immunocompromised individuals.
- The patient had a history of non-Hodgkin's lymphoma in complete remission.
Observation:
- A 63-year-old male presented with clinical and magnetic resonance imaging (MRI) findings suggestive of probable PML.
- The patient's neurological status and MRI scans were monitored.
- Neurological deficits included aphasia and motor impairment.
Findings:
- Introduction of intramuscular alpha-interferon therapy was followed by marked improvement.
- Neurological recovery included significant improvement in aphasia and motor function.
- MRI findings also demonstrated a clear positive response to treatment.
Implications:
- Alpha-interferon may represent a potential therapeutic option for progressive multifocal leukoencephalopathy.
- This case highlights the possibility of recovery from PML with specific treatments.
- Further research into interferon-based therapies for PML is warranted.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...